| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |